All three are gearing up for more growth.
These two stocks have been quietly making strides and could be long-term winners.
This could be a game changer for Green Thumb Industries.
These are all stocks that could be overdue for a rally if there's significant reform in the industry.
The impending cannabis rescheduling will have major impacts on the U.S. cannabis industry.
Magnificent growth stocks at bargain prices can still be found, even with the Nasdaq Composite reaching a fresh all-time high.
Despite a broad rally in cannabis, this top Canadian LP has failed to join the party.
The company's cost-cutting initiative and pivot to medical cannabis could pay big dividends for patient shareholders.
Canopy Growth stock has surged over 100% in 2024. Despite its recent gains, CGC stock remains a high-risk bet, due to its weak fundamentals and negative profit margins.
